Serum- and xeno-free cryopreservation of human umbilical cord tissue as mesenchymal stromal cell source

Cytotherapy

Volumn 17, Issue 5, 2015, Pages 593-600

  Shimazu, Takahisa ^a   Mori, Yuka ^a   Takahashi, Atsuko ^a   Tsunoda, Hajime ^b   Tojo, Arinobu ^a   Nagamura Inoue, Tokiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

Author keywords

Cryopreservation; Immunosuppression; Mesenchymal stromal cell; Umbilical cord

Indexed keywords

CRYOPROTECTIVE AGENT; STEM CELLBANKER; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; SERUM-FREE MEDIUM;

ADIPOCYTE; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; CRYOPRESERVATION; FREEZE THAWING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; MESENCHYMAL STROMA CELL; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; UMBILICAL CORD; ANIMAL; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; CELL SEPARATION; CYTOLOGY; DRUG EFFECTS; FREEZING; GENETICS; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; OSTEOBLAST; PROCEDURES; SERUM-FREE MEDIUM; T LYMPHOCYTE;

ANIMALIA;

ADIPOCYTES; ANIMALS; BIOMARKERS; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CHONDROCYTES; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; CULTURE MEDIA, SERUM-FREE; FREEZING; HUMANS; IMMUNOSUPPRESSION; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; T-LYMPHOCYTES; UMBILICAL CORD;

EID: 84933557345     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2015.03.604     Document Type: Article

References (27)

1. Gnecchi M., Melo L.G. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol Biol 2009, 482:281-294.
2. Bieback K., Kluter H. Mesenchymal stromal cells from umbilical cord blood. Current Stem Cell Res Ther 2007, 2:310-323.
3. In't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., de Groot-Swings G.M., Claas F.H., Fibbe W.E., et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004, 22:1338-1345.
4. Gruber H.E., Deepe R., Hoelscher G.L., Ingram J.A., Norton H.J., Scannell B., et al. Human adipose-derived mesenchymal stem cells: direction to a phenotype sharing similarities with the disc, gene expression profiling, and coculture with human annulus cells. Tissue Eng Part A 2010, 16:2843-2860.
5. Tong C.K., Vellasamy S., Tan B.C., Abdullah M., Vidyadaran S., Seow H.F., et al. Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method. Cell Biol Int 2011, 35:221-226.
6. Salehinejad P., Alitheen N.B., Ali A.M., Omar A.R., Mohit M., Janzamin E., et al. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly. InVitro Cell Dev Biol Anim 2012, 48:75-83.
7. Han Y.F., Tao R., Sun T.J., Chai J.K., Xu G., Liu J. Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods. Cytotechnology 2013, 65:819-827.
8. Margossian T., Reppel L., Makdissy N., Stoltz J.F., Bensoussan D., Huselstein C. Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and invitro expansion. Biomed Mater Eng 2012, 22:243-254.
9. Ishige I., Nagamura-Inoue T., Honda M.J., Harnprasopwat R., Kido M., Sugimoto M., et al. Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord. Int J Hematol 2009, 90:261-269.
10. He H., Nagamura-Inoue T., Tsunoda H., Yuzawa M., Yamamoto Y., Yorozu P., et al. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency. Tissue Eng Part A 2014, 20:1314-1324.
11. Mori Y., Ohshimo J., Shimazu T., He H., Takahashi A., Yamamoto Y., et al. Improved Explant Method To Isolate Umbilical Cord-derived Mesenchymal Stem Cells And Their Immunosuppressive Properties. Tissue Eng Part C Methods 2015, 21:1-6.
12. Wang L., Ji H., Zhou J., Xie J., Zhong Z., Li M., et al. Therapeutic potential of umbilical cord mesenchymal stromal cells transplantation for cerebral palsy: a case report. Case Rep Transplant 2013, 2013:146347.
13. Wei L., Zhang J., Xiao X.B., Mai H.X., Zheng K., Sun W.L., et al. Multiple injections of human umbilical cord-derived mesenchymal stromal cells through the tail vein improve microcirculation and the microenvironment in a rat model of radiation myelopathy. JTransl Med 2014, 12:246.
14. Jin J.L., Liu Z., Lu Z.J., Guan D.N., Wang C., Chen Z.B., et al. Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia. Current Neurovasc Res 2013, 10:11-20.
15. Rubinstein P., Dobrila L., Rosenfield R.E., Adamson J.W., Migliaccio G., Migliaccio A.R., et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995, 92:10119-10122.
16. Seshareddy K., Troyer D., Weiss M.L. Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord. Methods Cell Biol 2008, 86:101-119.
17. Saliem M., Holm F., Tengzelius R.B., Jorns C., Nilsson L.M., Ericzon B.G., et al. Improved cryopreservation of human hepatocytes using a new xeno free cryoprotectant solution. World J Hepatol 2012, 4:176-183.
18. Al-Saqi S.H., Saliem M., Quezada H.C., Ekblad A., Jonasson A.F., Hovatta O., et al. Defined serum- and xeno-free cryopreservation of mesenchymal stem cells. Cell Tissue Bank 2014, 1-13.
19. Illouz S., Nakamura T., Webb M., Thava B., Bikchandani J., Robertson G., et al. Comparison of University of Wisconsin and ET-Kyoto preservation solutions for the cryopreservation of primary human hepatocytes. Transplant Proc 2008, 40:1706-1709.
20. Holm F., Strom S., Inzunza J., Baker D., Stromberg A.M., Rozell B., et al. An effective serum- and xeno-free chemically defined freezing procedure for human embryonic and induced pluripotent stem cells. Hum Reprod 2010, 25:1271-1279.
21. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
22. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005, 7:393-395.
23. Ennis J., Sarugaser R., Gomez A., Baksh D., Davies J.E. Isolation, characterization, and differentiation of human umbilical cord perivascular cells (HUCPVCs). Methods Cell Biol 2008, 86:121-136.
24. Roy S., Arora S., Kumari P., Ta M. Asimple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells. Cryobiology 2014, 68:467-472.
25. Prasanna S.J., Gopalakrishnan D., Shankar S.R., Vasandan A.B. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS one 2010, 5:e9016.
26. Santos J.M., Barcia R.N., Simoes S.I., Gaspar M.M., Calado S., Agua-Doce A., et al. The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX(R)) in the treatment of inflammatory arthritis. JTransl Med 2013, 11:18.
27. Hsieh J.Y., Fu Y.S., Chang S.J., Tsuang Y.H., Wang H.W. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev 2010, 19:1895-1910.